Pfizer Payout Strains: Income Investors Face Hard Truth
Pfizer paid more in dividends than its free cash flow in 2025, a warning sign for income investors facing hard realit...
Wealth building strategies for young adults are essential. Discover ways to grow your wealth and achieve financial goals.
15,651 articlesPfizer paid more in dividends than its free cash flow in 2025, a warning sign for income investors facing hard realit...
The Fundrise VCX fund, once a magnet for IPO-obsessed investors, dropped 45% from its peak as market enthusiasm for p...
A fresh pullback can create smart entry points. This guide highlights my top 3 financial stocks after latest market p...
Investors are seeing a mining stock flying this week, led by SSR Mining. This piece breaks down the catalysts beyond ...
The Dow rose above a key threshold—49,683.30—on Thursday, putting it on a path to officially exit correction territor...
Finance of America reported a profitable first quarter, reversing Q4 losses as originations climbed and portfolio gai...
As ELAN reports Q1 2026 earnings, investors want clarity on growth, margins, and guidance. This analysis breaks down ...
Celanese (CE) stands at an inflection point as 2026 begins. This article breaks down the potential drivers behind cel...
As investors retire or near retirement, the tax treatment of dividend income matters as much as the yield. This expla...
A midstream-focused energy ETF aims to deliver reliable income through toll-road style fees rather than volatile comm...
Magnolia (MGY) is delivering a pivotal Q1 2026 performance that tests the durability of its business model. This arti...
A clear, investor-focused read on what The Trade Desk's Q1 2026 results mean for 2026. Discover growth drivers, margi...